S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

RHÖN-KLINIKUM Aktiengesellschaft (RHK) Stock Forecast, Price & News

-0.15 (-0.99%)
(As of 05/20/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
3,821 shs
Average Volume
43,281 shs
Market Capitalization
$1.00 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive RHK News and Ratings via Email

Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

RHÖN-KLINIKUM Aktiengesellschaft logo

About RHÖN-KLINIKUM Aktiengesellschaft

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.


See More Headlines

Industry, Sector and Symbol

Medical Care
Year Founded

Sales & Book Value

Annual Sales
$1.59 billion
Cash Flow
€4.38 per share
Book Value
€17.90 per share


Pretax Margin




Free Float
Market Cap
$1.00 billion
Not Optionable

Company Calendar

Next Earnings (Estimated)


Overall MarketRank

1.23 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK) Frequently Asked Questions

When is RHÖN-KLINIKUM Aktiengesellschaft's next earnings date?

RHÖN-KLINIKUM Aktiengesellschaft is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for RHÖN-KLINIKUM Aktiengesellschaft

Is RHÖN-KLINIKUM Aktiengesellschaft a good dividend stock?

RHÖN-KLINIKUM Aktiengesellschaft pays an annual dividend of €0.29 per share and currently has a dividend yield of 1.60%. The dividend payout ratio of RHÖN-KLINIKUM Aktiengesellschaft is 69.05%. This payout ratio is at a healthy, sustainable level, below 75%.

Who are RHÖN-KLINIKUM Aktiengesellschaft's key executives?
RHÖN-KLINIKUM Aktiengesellschaft's management team includes the following people:
  • Dr. Christian Hoftberger, Chairman of Management Board & CEO (Age 47, Pay $667k)
  • Dr. Stefan Stranz, CFO & Member of Management Board (Age 45, Pay $701k)
  • Prof. Bernd Griewing, Chief Medical Officer & Member of Board of Management (Age 60, Pay $1.37M)
  • Dr. Gunther Karl Weiß M.Sc., COO & Member of Management Board (Age 54, Pay $1.03M)
  • Mr. Jörg Demmler, Head of Technical Controlling & Environment (Age 70)
  • Julian Schmitt, Head of Investor Relations & Treasury
  • Elke Pfeifer, Head of Corp. Communications and Marketing
  • Mr. Eugen Münch, Chief Representative
  • Mr. Franz Mlynek, Divisional Head of Major Investments (Age 70)
  • Esther Walter, Head of Group Press and PR
What other stocks do shareholders of RHÖN-KLINIKUM Aktiengesellschaft own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RHÖN-KLINIKUM Aktiengesellschaft investors own include Seabridge Gold (SA), iShares Silver Trust (SLV), Walt Disney (DIS), Alamos Gold (AGI), Anova Metals (AWV), Bayerische Motoren Werke Aktiengesellschaft (BMW), Anheuser-Busch InBev SA/NV (BUD), Cognex (CGNX), Canadian National Railway (CNI) and Warner Bros. Discovery (DISCK).

What is RHÖN-KLINIKUM Aktiengesellschaft's stock symbol?

RHÖN-KLINIKUM Aktiengesellschaft trades on the ETR under the ticker symbol "RHK."

What is RHÖN-KLINIKUM Aktiengesellschaft's stock price today?

One share of RHK stock can currently be purchased for approximately €14.95.

How much money does RHÖN-KLINIKUM Aktiengesellschaft make?

RHÖN-KLINIKUM Aktiengesellschaft has a market capitalization of $1.00 billion and generates $1.59 billion in revenue each year.

How many employees does RHÖN-KLINIKUM Aktiengesellschaft have?

RHÖN-KLINIKUM Aktiengesellschaft employs 10,143 workers across the globe.

What is RHÖN-KLINIKUM Aktiengesellschaft's official website?

The official website for RHÖN-KLINIKUM Aktiengesellschaft is www.rhoen-klinikum-ag.com.

How can I contact RHÖN-KLINIKUM Aktiengesellschaft?

RHÖN-KLINIKUM Aktiengesellschaft's mailing address is Schlossplatz 1, BAD NEUSTADT AN DER SAALE, 97616, Germany. The company can be reached via phone at +49-9-771650.

This page was last updated on 5/22/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.